Serotonin Levels and Platelet Uptake during Premenstrual Tension
Abstract
Premenstrual tension was studied in 16 females, using both biochemical and psychological parameters during the pre- and postmenstrual phases. Uptake of serotonin (5-HT) and the levels of 5-HT in platelet-rich plasma and platelet-poor plasma were determined. Degrees of distress experienced pre- and postmenstrually were quantified via the Moos menstrual distress questionnaire. The mean V max was significantly lower during the premenstrual (tension) phase (8.2 ± 0.9 pmol/min) as compared to the postmenstrual (normal) phase (14.4 ± 3.2 pmol/min). There was no significant difference in the K m values. A highly significant (p < 0.001) reduction in the levels of 5-HT in platelet-rich plasma (–23.2%) and platelet-poor plasma (-19.1%) was found during the premenstrual phase. There were correlations between the kinetic parameters of 5-HT uptake and some of the Moos symptoms.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
PMDD patients have reduced plasma and whole-blood serotonin levels compared with controls.
“Experimental evidence implicating the serotonergic system includes findings of reduced plasma- [101] and whole-blood [102] serotonin levels in patients compared to controls.”
From Sleep, hormones, and circadian rhythms throughout the menstrual cycle in healthy women and women with premenstrual dysphoric disorder (2010) · cites this paper as [101]
Cited by
Sorted by citations
The lower limb flexion reflex in humans
Sandrini, G., Serrao, M., Rossi, P., Romaniello, A., Cruccu, G., & Willer, J. C. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.11.003 · Cited by 508 · see citing works
Selective serotonin reuptake inhibitors for premenstrual syndrome.
Marjoribanks, J., Brown, J., O'Brien, P., & Wyatt, K. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001396.pub3 · Cited by 180 · see citing works
The etiology, biology, and evolving pathology of premenstrual syndromes
Halbreich, U. M. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(03)00097-0 · Cited by 305 · see citing works
Menstrual cycle and appetite control: implications for weight regulation
Dye, L., & Blundell, J. E. (1997) · Human Reproduction · doi:10.1093/humrep/12.6.1142 · Cited by 304 · see citing works
“The more premenstrually (Taylor et al., 1984; Tam et al., 1985).”
Shechter, A., & Boivin, D. B. (2010) · International Journal of Endocrinology · doi:10.1155/2010/259345 · Cited by 194 · see citing works
“Experimental evidence implicating the serotonergic system includes findings of reduced plasma- [101] and whole-blood [102] serotonin levels in patients compared to controls.”
BackgroundAn engineered IL-2 partial agonist promotes CD8+ T cell stemness
Mo, F., Yu, Z., Li, P., Oh, J., Spolski, R. J., Zhao, L., Glassman, C. R., Yamamoto, T. N., Chen, Y., Gołębiowski, F., et al. (2021) · Nature · doi:10.1038/s41586-021-03861-0 · Cited by 183 · see citing works
Depression and weight gain: the serotonin connection
Wurtman, J. J. (1993) · Journal of Affective Disorders · doi:10.1016/0165-0327(93)90032-f · Cited by 149 · see citing works
Venlafaxine in the treatment of premenstrual dysphoric disorder*1
Freeman, E. W. (2001) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(01)01530-7 · Cited by 128 · see citing works
Ashby, C. R., Carr, L. A., Cook, C. L., Steptoe, M. M., & Franks, D. D. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90277-6 · Cited by 122 · see citing works
Selective serotonin reuptake inhibitors for premenstrual syndrome
Brown, J., O’Brien, P. M. S., Marjoribanks, J., & Wyatt, K. M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001396.pub2 · Cited by 115 · see citing works
Premenstrual dysphoric disorder and psychiatric co-morbidity
Kim, D. R., Gyulai, L., Freeman, E. W., Morrison, M. F., Baldassano, C. F., & Dub�, B. (2004) · Archives of Women s Mental Health · doi:10.1007/s00737-003-0027-3 · Cited by 108 · see citing works
Premenstrual syndrome, a common but underrated entity: review of the clinical literature
Dilbaz, B., & Aksan, A. (2021) · Journal of the Turkish-German Gynecological Association · doi:10.4274/jtgga.galenos.2021.2020.0133 · Cited by 112 · see citing works
“Current evidence suggests that PMS is a disorder triggered by changes in gonadal steroids during the LPMC in susceptible women.”
BackgroundInfluentialThe premenstrual syndrome – a reappraisal of the concept and the evidence
Bancroft, J. (1993) · Psychological Medicine Monograph Supplement · doi:10.1017/s0264180100001272 · Cited by 102 · see citing works
Pilver, C. E., Libby, D. J., & Hoff, R. A. (2012) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-012-0548-z · Cited by 85 · see citing works
“Correspondingly, researchers have noted that in the premenstrual phase, women with PMDD have lower whole blood serotonin levels and lower platelet serotonin uptake than women without PMDD [30, 31].”
A controlled study of light therapy in women with late luteal phase dysphoric disorder
Lam, R. W., Carter, D., Misri, S., Kuan, A. J., Yatham, L. N., & Zis, A. P. (1999) · Psychiatry Research · doi:10.1016/s0165-1781(99)00043-8 · Cited by 85 · see citing works
“Other studies indicate dysregulation of seroŽtonergic function in LLPDD Taylor et al., 1984; Rapkin et al., 1987; Halbreich and Tworek, 1993; .”
BackgroundThe Efficacy of Hypericum perforatum (St Johnʼs Wort) for the Treatment of Premenstrual Syndrome
Canning, S. E., Waterman, M. G., Orsi, N. M., Ayres, J., Simpson, N., & Dye, L. (2010) · CNS Drugs · doi:10.2165/11530120-000000000-00000 · Cited by 86 · see citing works
Changes in Nociceptive Flexion Reflex Threshold Across the Menstrual Cycle in Healthy Women
Tassorelli, C., Sandrini, G., Cecchini, A. P., Nappi, R. E., Sances, G., & Martignoni, E. (2002) · Psychosomatic Medicine · doi:10.1097/01.psy.0000021945.35402.0d · Cited by 83 · see citing works
Full- or Half-Cycle Treatment of Severe Premenstrual Syndrome With a Serotonergic Antidepressant
Freeman, E. W., Rickels, K., Arredondo, F., Kao, L.-C., Pollack, S. E., & Sondheimer, S. J. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199902000-00002 · Cited by 75 · see citing works
Evaluation and Management of Premenstrual Syndrome and Premenstrual Dysphoric Disorder
Frackiewicz, E. J., & Shiovitz, T. M. (2001) · Journal of the American Pharmaceutical Association (1996) · doi:10.1016/s1086-5802(16)31257-8 · Cited by 68 · see citing works
Ducasse, D., Jaussent, I., Olié, É., Guillaume, S., López‐Castromán, J., & Courtet, P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148653 · Cited by 63 · see citing works
Luteal Phase Administration of Agents for the Treatment of Premenstrual Dysphoric Disorder
Freeman, E. W. (2004) · CNS Drugs · doi:10.2165/00023210-200418070-00004 · Cited by 63 · see citing works
Steiner, M. S. (1997) · Annual Review of Medicine · doi:10.1146/annurev.med.48.1.447 · Cited by 63 · see citing works
Serotonin, Carbohydrates, and Atypical Depression
Møller, S. E. (1992) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1992.tb01630.x · Cited by 62 · see citing works
Advances in the Diagnosis and Treatment of Premenstrual Dysphoria
Steiner, M. S., & Born, L. (2000) · CNS Drugs · doi:10.2165/00023210-200013040-00005 · Cited by 56 · see citing works
The Role of Central Serotonergic Dysfunction in the Aetiology of Premenstrual Dysphoric Disorder
Parry, B. L. (2001) · CNS Drugs · doi:10.2165/00023210-200115040-00003 · Cited by 54 · see citing works
The Influence of Serotonin Deficiency on Choice Deferral and the Compromise Effect
Lichters, M., Brunnlieb, C., Nave, G., Sarstedt, M., & Vogt, B. (2015) · Journal of Marketing Research · doi:10.1509/jmr.14.0482 · Cited by 53 · see citing works
“…that marketing strategies that systematically incorporate the compromise effect with the intent to promote the choice of an intermediate compromise option might be less effective when the target population’s serotonin levels are lowered (e.g., at old age or duringwinter; Taylor et al. 1984).”
BackgroundCerebrospinal Fluid Levels of Monoamine Metabolites
Eriksson, E., Alling, C., Andersch, B., Andersson, K., & Berggren, U. (1994) · Neuropsychopharmacology · doi:10.1038/sj.npp.1380107 · Cited by 54 · see citing works
Ehlers, C. L., Phillips, E., & Parry, B. L. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00183-2 · Cited by 49 · see citing works
Models for the Development and Expression of Symptoms in Premenstrual Syndrome
Rubinow, D. R., & Schmidt, P. J. (1989) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30451-9 · Cited by 47 · see citing works
Selective serotonin reuptake inhibitors for premenstrual syndrome
Brown, J., O’Brien, P. M. S., Marjoribanks, J., & Wyatt, K. M. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001396 · Cited by 46 · see citing works
Chinese herbal medicine for premenstrual syndrome
Jing, Z., Yang, X., ISMAIL, K. M. K., Chen, X. Y., & Wu, T. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006414.pub2 · Cited by 46 · see citing works
Roomruangwong, C., Kanchanatawan, B., Sirivichayakul, S., Anderson, G., Carvalho, A. F., Duleu, S., Geffard, M., & Maes, M. H. J. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9877-3 · Cited by 41 · see citing works
Depression and Its Effect on the Menstrual Cycle
Padda, J., Khalid, K., Hitawala, G., Batra, N., Pokhriyal, S. C., Mohan, A., Zubair, U., Cooper, A. C., & Jean-Charles, G. (2021) · Cureus · doi:10.7759/cureus.16532 · Cited by 45 · see citing works
Schmitt, J. A. J., Jorissen, B. L., Dye, L., Markus, C. R., Deutz, N. E. P., & Riedel, W. J. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105053288 · Cited by 43 · see citing works
Melke, J., Westberg, L., Landén, M., et al. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00033-1 · Cited by 42 · see citing works
“, 1992), as well as studies reporting reduced platelet uptake of serotonin in women with PMD (Taylor et al., 1984; Ashby et al., 1988).”
BackgroundReduced platelet tritium-labeled imipramine binding sites in women with premenstrual syndrome
Steege, J. F., Stout, A. L., Knight, D. L., et al. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(11)91653-6 · Cited by 42 · see citing works
Yatham, L. N. (1993) · The Canadian Journal of Psychiatry · doi:10.1177/070674379303801007 · Cited by 42 · see citing works
“decreased 5-HT uptake into platelets (2,3); and 3.”
BackgroundNeuroendocrine response to an intravenous L-tryptophan challenge in women with premenstrual syndrome
Rasgon, N., McGuire, M. T., Tanavoli, S., Fairbanks, L. A., & Rapkin, A. J. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00452-5 · Cited by 41 · see citing works
Premenstrual Syndrome and Exercise: A Narrative Review
Sanchez, B. N., Kraemer, W. J., & Maresh, C. M. (2023) · Women · doi:10.3390/women3020026 · Cited by 47 · see citing works
A biopsychosocial approach to premenstrual dysphoric disorder
Ross, L. E., & Steiner, M. S. (2003) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(03)00035-2 · Cited by 38 · see citing works
“PMDD patients have lower whole blood serotonin levels [44] and lower platelet serotonin uptake [45] during the premenstrual phase.”
BackgroundPremenstrual dysphoric disorder: a review for the treating practitioner.
Kaur, G., Gonsalves, L., & Thacker, H. L. (2004) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.71.4.303 · Cited by 36 · see citing works
Rasgon, N., Serra, M., Biggio, G., Pisu, M. G., Fairbanks, L. A., Tanavoli, S., & Rapkin, A. J. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450025 · Cited by 35 · see citing works
“Subsequently other investigators have demonstrated decreased platelet uptake of serotonin in women with PMS ( 2 ) and there are numerous reports that administration of SSRIs and other serotonergic agonists leads to improvement in the symptoms of PMS/PMDD (3, 4, 22, 23).”
BackgroundResultInfluentialFreeman, E. W. (2002) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2002.4.2/efreeman · Cited by 33 · see citing works
Effective open‐label treatment of premenstrual dysphoric disorder with venlafaxine
Hsiao, M., & Liu, C. (2003) · Psychiatry and Clinical Neurosciences · doi:10.1046/j.1440-1819.2003.01123.x · Cited by 33 · see citing works
Alteration of 5-HT uptake by plasma fractions in the premenstrual syndrome
Ashby, C. R., Carr, L. A., Cook, C. L., Steptoe, M. M., & Franks, D. D. (1990) · Journal of Neural Transmission · doi:10.1007/bf01250999 · Cited by 33 · see citing works
Menstrual cycle effects on the metabolism of tryptophan loads
Hrboticky, N., Leiter, L. A., & Anderson, G. H. (1989) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/50.1.46 · Cited by 32 · see citing works
Serotonin and gender-specific psychiatric disorders
Steiner, M. S., Lepage, P., & Dunn, E. J. (1997) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651509709069200 · Cited by 30 · see citing works
A Risk-Benefit Appraisal of Drugs Used in the Management of Premenstrual Syndrome
Mortola, J. F. (1994) · Drug Safety · doi:10.2165/00002018-199410020-00005 · Cited by 30 · see citing works
Venlafaxine in the Treatment of Premenstrual Dysphoric Disorder
Freeman, E. W., Rickels, K., Yonkers, K. A., Kunz, N. R., McPherson, M., & Upton, G. V. (2001) · Obstetrics and Gynecology · doi:10.1097/00006250-200111000-00006 · Cited by 30 · see citing works
Psychiatric evaluation of premenstrual changes
Harrison, W. M., Rabkin, J. G., & Endicott, J. (1985) · Psychosomatics · doi:10.1016/s0033-3182(85)72792-2 · Cited by 29 · see citing works
The menstrual cycle and platelet 5-HT uptake.
Tam, W. Y., Chan, M., & Lee, P. H. (1985) · Psychosomatic Medicine · doi:10.1097/00006842-198507000-00005 · Cited by 28 · see citing works
“(14), we were unable to obtain significant correlation between any of the mood items and platelet 5-HT uptake kinetic parameters.”
BackgroundInfluentialSerotonergic function and late luteal phase dysphoric disorder
Veeninga, A. T., & Westenberg, H. G. M. (1992) · Psychopharmacology · doi:10.1007/bf02245301 · Cited by 27 · see citing works
Serotonin and measured intelligence
Cook, E. H., LEVENTHAL, B. L., & Freedman, D. X. (1988) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02211873 · Cited by 26 · see citing works
Approach to Premenstrual Dysphoria for the Mental Health Practitioner
Vigod, S. N., Frey, B. N., Soares, C. N., & Steiner, M. S. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2010.01.008 · Cited by 25 · see citing works
Pharmacotherapy of premenstrual syndromes and premenstrual disphoric disorder: current practices
Mitwally, M. F., Kahn, L. S., & Halbreich, U. M. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.11.1577 · Cited by 25 · see citing works
“Serotonergic dysfunction in PMS also has been suggested on the basis of findings of decreased platelet uptake of serotonin [23], blunted response to 5-HT agonists [24] and consistent therapeutic efficacy of selective serotonergic re-uptake inhibitors (SSRIs) in the treatment of this disorder [25-27].”
BackgroundBixo, M., Allard, P. O., Bäckström, T. C., et al. (2001) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(01)00010-5 · Cited by 24 · see citing works
“, 1994), the present findings should indirectly implicate increased uptake of 5-HT, contradictory to findings of decreased premenstrual uptake of 5-HT into platelets in PMDD (Taylor et al., 1984; Ashby et al., 1988).”
ResultDissociative Experiences and Eating Disorders
Goldner, E. M., Cockhill, L. A., Bakan, R., & Birmingham, C. L. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.9.1274-b · Cited by 24 · see citing works
Shams‐Alizadeh, N., Maroufi, A., Rashidi, M., Roshani, D., Farhadifar, F., & Khazaie, H. (2018) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2018.01.003 · Cited by 22 · see citing works
Exploratory study of premenstrual symptoms and serotonin variability
Clayton, A. H., Keller, A. E., Leslie, C. E., & Evans, W. (2005) · Archives of Women s Mental Health · doi:10.1007/s00737-005-0118-4 · Cited by 22 · see citing works
“The second showed a decreased Vmax of 5-HT uptake and 5-HT content in the platelets of PMS patients (Taylor et al, 1984).”
BackgroundDecreased central opioid activity in premenstrual syndrome: Luteinizing hormone response to naloxone
Rapkin, A. J., Shoupe, D., Reading, A. E., et al. (1996) · Journal of the Society for Gynecologic Investigation · doi:10.1016/1071-5576(95)00045-3 · Cited by 22 · see citing works
Pain Sensitivity in Women with Premenstrual Dysphoric Disorder: A Preliminary Report
Fillingim, R. B., Girdler, S. S., Booker, D., Light, K. C., Harris, M. B., & Maixner, W. D. (1995) · Journal of Women s Health · doi:10.1089/jwh.1995.4.367 · Cited by 21 · see citing works
“Similarly, some studies report impaired serotonergic function premenstrually in PDD sufferers compared with controls,14-16 while others do not support the serotonin hypothesis.17'18 Thus, the etiology of PDD remains unclear.”
Serotonin (5‐HT) uptake by blood platelets in anorexia nervosa
Zemishlany, Z., Modai, I., Apter, A. S., et al. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb02763.x · Cited by 21 · see citing works
Le syndrome prémenstruel: revue générale
Zaafrane, F., Faleh, R., Melki, W., Sakouhi, M., & Gaha, L. (2007) · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction · doi:10.1016/j.jgyn.2007.01.007 · Cited by 20 · see citing works
Circadian and circatrigintan rhythms of biogenic amines in premenstrual syndrome (PMS).
Odink, J., van der Ploeg, H. M., van den Berg, H., et al. (1990) · Psychosomatic Medicine · doi:10.1097/00006842-199005000-00008 · Cited by 20 · see citing works
“Although Malmgren et al. (34) did not observe differences between PMS patients and control subjects in serotonin uptake by platelets, the results of several studies ( 35-38 ) indicate a reduced peripheral serotonin metabolism in PMS and are thus suggestive of a reduced central serotonergic activity.”
ResultProgesterone, GABA and mood disorders in women
Rapkin, A. J. (1999) · Archives of Women s Mental Health · doi:10.1007/s007370050041 · Cited by 19 · see citing works
“Decreased platelet uptake of serotonin and decreased whole blood serotonin have all been documented in individuals with major depressive disorder and PMS (Meltzer, 1990; LeQuan-Bui et al., 1984; Lopez-Ibor, 1988; Taylor et al., 1984; Rapkin et al., 1987).”
BackgroundAbnormal platelet 5-hydroxytryptamine uptake and imipramine binding in postnatal dysphoria
Hannah, P., Adams, D., Glover, V. A. S., & Sandler, M. (1992) · Journal of Psychiatric Research · doi:10.1016/0022-3956(92)90017-i · Cited by 18 · see citing works
Vigod, S. N., Ross, L. E., & Steiner, M. S. (2009) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2009.10.010 · Cited by 18 · see citing works
Evaluation of drug-induced injury and human response in precision-cut tissue slices
Vickers, A. E. M., & Fisher, R. L. (2012) · Xenobiotica · doi:10.3109/00498254.2012.732714 · Cited by 18 · see citing works
Pharmacological Management of Premenstrual Disorder
Altshuler, L. L., Hendrick, V. C., & Parry, B. L. (1995) · Harvard Review of Psychiatry · doi:10.3109/10673229509017143 · Cited by 18 · see citing works
Parveen, T., Kamran, M., & Fatmi, M. Q. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.01.022 · Cited by 17 · see citing works
Development and validation of an improved radioimmunoassay for serotonin in platelet-rich plasma
Gow, I. F., Corrie, J. E. T., Williams, B. C., et al. (1987) · Clinica Chimica Acta · doi:10.1016/0009-8981(87)90449-9 · Cited by 17 · see citing works
Treatment of premenstrual dysphoric disorder with luteal phase dosing of sertraline
Halbreich, U. M., & Kahn, L. S. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.11.2065 · Cited by 16 · see citing works
Platelet monoamine oxidase B activity in women with premenstrual syndrome
Rapkin, A. J., Buckman, T. D., Sutphin, M. S., et al. (1988) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(88)90590-x · Cited by 15 · see citing works
Premenstrual Dysphoric Disorder
Elliott, H. (2002) · North Carolina Medical Journal · doi:10.18043/ncm.63.2.72 · Cited by 15 · see citing works
Rosenstein, D. L., Kalogeras, K. T., Kalafut, M. A., Malley, J. D., & Rubinow, D. R. (1996) · Psychoneuroendocrinology · doi:10.1016/0306-4530(95)00035-6 · Cited by 14 · see citing works
Tryptophan loading test in premenstrual syndrome
Rapkin, A. J., Chung, L., Reading, A. E., et al. (1989) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443618909151136 · Cited by 13 · see citing works
Verapamil treatment of premenstrual syndrome
Deicken, R. F. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90142-4 · Cited by 13 · see citing works
Tryptophan and neutral amino acids in premenstrual syndrome
Rapkin, A. J., Reading, A. E., Woo, S., et al. (1991) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(91)90040-x · Cited by 12 · see citing works
Tryptophan and its role in sleep and mood
Yousef, P., Rosen, J., & Shapiro, C. M. (2024) · Studies in natural products chemistry · doi:10.1016/b978-0-443-15589-5.00001-3 · Cited by 11 · see citing works
Haußmann, J., Goeckenjan, M., Haußmann, R., & Wimberger, P. (2024) · Der Nervenarzt · doi:10.1007/s00115-024-01625-5 · Cited by 12 · see citing works
Premenstrual dysphoric disorder: literature review
Fryer, C., Kaspi, S. P., Fallon, S. K., Moline, M. L., & Severino, S. K. (1999) · Archives of Women s Mental Health · doi:10.1007/s007370050031 · Cited by 9 · see citing works
“…2) premenstrual decreased latency to rapid eye movement on sleep EEG (Unden and Christensen 1986), 3) luteal phase decrease in plasma B-endorphin (Facchinetti et al., 1987, Chuong et al., 1985), and 4) luteal phase decrease in platelet serotonin uptake (Taylor et al., 1984, Ashby et al., 1988).”
BackgroundPremenstrual syndrome: current knowledge and management.
Robinson, G. E. (1989) · PubMed · Cited by 10 · see citing works
Late luteal phase dysphoric disorder: A scientific puzzle
Severino, S. K. (1993) · Medical Hypotheses · doi:10.1016/0306-9877(93)90236-j · Cited by 9 · see citing works
Severino, S. K., & Moline, M. L. (1990) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(21)00455-1 · Cited by 8 · see citing works
Premenstrual Dysphoric Disorder
Nowakowski, S., Haynes, P. L., & Parry, B. L. (2007) · Elsevier eBooks · doi:10.1016/b978-012373947-6.00304-4 · Cited by 9 · see citing works
The pathophysiologic background for current treatments of premenstrual syndromes
Halbreich, U. M. (2002) · Current Psychiatry Reports · doi:10.1007/s11920-002-0070-1 · Cited by 7 · see citing works
“The decrease of some 5-HT parameters during the symptomatic premenstrual period has been demonstrated for serotonin uptake, which was reduced in women with PMS [25, 26 ] and was lower than in women with no PMS [27,28], in platelets.”
BackgroundAshby, C. R., Carr, L. A., Cook, C. L., et al. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90164-u · Cited by 7 · see citing works
Intermittent, luteal phase nefazodone treatment of premenstrual dysphoric disorder
Kodesh, A., Katz, S., Lerner, A., et al. (2001) · Journal of Psychopharmacology · doi:10.1177/026988110101500110 · Cited by 7 · see citing works
Fluoxetine and Preoccupation With Suicide
Balon, R. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.9.1260 · Cited by 7 · see citing works
Ramos, M. F., Uribe, M. O., & Sotres, J. C. (2003) · Salud Mental · Cited by 6 · see citing works
Reflections on the Cause of Premenstrual Syndrome
Halbreich, U. M. (1996) · Psychiatric Annals · doi:10.3928/0048-5713-19960901-11 · Cited by 6 · see citing works
Collins, A. (1991) · Springer eBooks · doi:10.1007/978-1-4615-3712-0_13 · Cited by 6 · see citing works
9 The premenstrual syndrome: a psychoneuroendocrine perspective
Dinan, T. G., & O’Keane, V. (1991) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80101-6 · Cited by 6 · see citing works
Steiner, M. S., Judge, R., & Kumar, R. (1997) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651509709024735 · Cited by 6 · see citing works
Premenstrual syndrome/premenstrual dysphoric disorder
Washington, M., Brown, C., & Ling, F. W. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139628938.004 · Cited by 5 · see citing works
Recognizing and Treating Premenstrual Dysphoric Disorder
Liang, B. A., Batra, P., & Harper, D. M. (2002) · Cited by 5 · see citing works
Premenstrual Dysphoric Disorder
Parry, B. L., Nowakowski, S., Martinez, L. F., & Berga, S. L. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00094-2 · Cited by 4 · see citing works
Dog, T. L. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1793-8.00106-0 · Cited by 4 · see citing works
Gonadal Hormones and Behavior in Women: Concentrations versus Context
Rubinow, D. R., Schmidt, P. J., Meltzer-Brody, S. E., & Harsh, V. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00076-0 · Cited by 4 · see citing works
Non-hormonal therapy of premenstrual syndrome
Martignoni, E., Desideri, S., Sances, G., et al. (1997) · Cephalalgia · doi:10.1177/0333102497017s2007 · Cited by 4 · see citing works
- Authors
- Taylor, D. L., Mathew, R. J., Ho, B. T., & Weinman, M. L.
- ORCID
- Weinman, Maxine L.
- Venue
- Neuropsychobiology
- Publisher
- S. Karger AG
- Published
- 2008-02-19
- Volume
- 12
- Issue
- 1
- Pages
- 16-18
- ISSN
- 0302-282X (ISSN-L)
- 1423-0224
- OpenAlex
- W2024348642
- Cited by
- 131
- References
- 0
- Citations by year
- 2026: 1 · 2024: 4 · 2023: 1 · 2022: 1 · 2021: 3 · 2019: 2 · 2018: 1 · 2017: 2 · 2016: 5 · 2015: 3 · 2013: 1 · 2012: 5
- FWCI
- 3.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuropsychobiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Menstrual Health and Disorders
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- premenstrual syndrome, serotonin, platelet uptake, platelet-rich plasma, platelet-poor plasma, menstrual cycle, menstrual distress, women
- MeSH terms
- Adolescent, Adult, Blood Platelets, Female, Humans, Kinetics, Premenstrual Syndrome, Serotonin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
